These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6992759)
1. Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus. Scott RS; Espiner EA; Donald RA; Ellis MJ Aust N Z J Med; 1980 Apr; 10(2):146-50. PubMed ID: 6992759 [TBL] [Abstract][Full Text] [Related]
3. Abnormalities of endogenous glucagon and insulin in unstable diabetes. Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563 [TBL] [Abstract][Full Text] [Related]
4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects. Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972 [TBL] [Abstract][Full Text] [Related]
6. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy. Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646 [TBL] [Abstract][Full Text] [Related]
7. Residual pancreatic function in insulin dependent diabetics. Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357 [TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics. Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193 [TBL] [Abstract][Full Text] [Related]
10. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941 [TBL] [Abstract][Full Text] [Related]
11. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects. Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989 [TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes. Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951 [TBL] [Abstract][Full Text] [Related]
13. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics]. Ferrero E; Casale G; Tassi G; Ciaponi A Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151 [TBL] [Abstract][Full Text] [Related]
14. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Frier BM; Ashby JP; Nairn IM; Baird JD Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620 [TBL] [Abstract][Full Text] [Related]
15. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal. Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876 [TBL] [Abstract][Full Text] [Related]
17. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813 [TBL] [Abstract][Full Text] [Related]
18. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841 [TBL] [Abstract][Full Text] [Related]
19. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855 [TBL] [Abstract][Full Text] [Related]
20. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus. Starke A; Keck E; Berger M; Zimmermann H Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]